JG
ESPR

Jefferies Group’s Esperion Therapeutics ESPR Stock Holding History

Jefferies Group’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,700
Closed -$936K – 2208
2019
Q4 		$936K Hold
15,700
– – 0.01% 1500
2019
Q3 		$576K Hold
15,700
– – ﹤0.01% 1807
2019
Q2 		$730K Buy
+15,700
New +$737K 0.01% 1464
2018
Q4 		– Sell
-26,600
Closed -$1.18M – 2255
2018
Q3 		$1.18M Buy
+26,600
New +$1.22M 0.01% 1247
2015
Q3 		– Sell
-242,800
Closed -$19.9M – 2497
2015
Q2 		$19.9M Buy
242,800
+205,600
+553% +$20.1M 0.1% 165
2015
Q1 		$3.44M Buy
+37,200
New +$2.4M 0.02% 558

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return